Across TCGA pan-cancer cohorts, MED15P4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MED15P4’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MED15P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MED15P4 is over-expressed in tumor.

BRCA, LUSC, and THCA are the cancer types where MED15P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MED15P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.646	<.001	6	view →
LUSC	All	All	+0.254	.013	2	view →
THCA	All	All	+0.013	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MED15P4 RNA expression & survival · all MED15P4 data types